Sage Therapeutics, Inc.
SAGEDelisted Jul 31, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001597553
Sage Therapeutics, Inc. was delisted on Jul 31, 2025; its insiders filed their last Form 4 on Jul 31, 2025; 192 institutions reported holding it in 13F filings for Q2 2025, worth $445.6M in total; no superinvestor held it.
13F holders, Q2 2025
Institutional positions in Sage Therapeutics, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
SAGE is no longer listed, so this page shows Q2 2025. 13F filings for later quarters list far fewer holders.
- Institutional holders
- 192
- −4 vs. Q1 2025
- Shares held
- 48.9M
- −2.88M (−5.6%) vs. Q1 2025
- Total value
- $445.6M
- +$34.2M (+8.3%) vs. Q1 2025
- New holders
- 38
- 59 more added
- Sold out
- 42
- 55 more reduced
2 institutions that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SAGE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $9 |
| Q1 2026 | 1 | $9 |
| Q4 2025 | 2 | $460.0K |
| Q3 2025 | 5 | $494.0K |
| Q2 2025 | 192 | $445.6M |
| Q1 2025 | 198 | $411.4M |
| Q4 2024 | 177 | $278.2M |
| Q3 2024 | 177 | $373.7M |
| Q2 2024 | 196 | $581.3M |
| Q1 2024 | 206 | $1.10B |
| Q4 2023 | 202 | $1.22B |
| Q3 2023 | 195 | $1.21B |
| Q2 2023 | 225 | $2.54B |
| Q1 2023 | 214 | $2.22B |
| Q4 2022 | 207 | $1.97B |
| Q3 2022 | 201 | $2.02B |
| Q2 2022 | 211 | $1.65B |
| Q1 2022 | 212 | $1.65B |
| Q4 2021 | 217 | $2.14B |
| Q3 2021 | 227 | $2.17B |
| Q2 2021 | 257 | $2.88B |
| Q1 2021 | 263 | $3.97B |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Sage Therapeutics, Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BML Capital Management, LLC | 0 | $0 | 0.00% | −135,095−100.0% | Sold out |
| Brevan Howard Capital Management LP | 0 | $0 | 0.00% | −131,987−100.0% | Sold out |
| DAFNA Capital Management LLC | 0 | $0 | 0.00% | −108,200−100.0% | Sold out |
| Kite Lake Capital Management (UK) LLP | 0 | $0 | 0.00% | −105,000−100.0% | Sold out |
| Quadrature Capital Ltd | 0 | $0 | 0.00% | −84,964−100.0% | Sold out |
| Polar Asset Management Partners Inc. | 0 | $0 | 0.00% | −82,318−100.0% | Sold out |
| Virtus Investment Advisers, Inc. | 0 | $0 | 0.00% | −63,321−100.0% | Sold out |
| Persistent Asset Partners Ltd | 0 | $0 | 0.00% | −42,216−100.0% | Sold out |
| ClearAlpha Technologies LP | 0 | $0 | 0.00% | −40,000−100.0% | Sold out |
| Diametric Capital, LP | 0 | $0 | 0.00% | −39,276−100.0% | Sold out |
| Easterly Investment Partners LLC | 0 | $0 | 0.00% | −27,000−100.0% | Sold out |
| Integrated Wealth Concepts LLC | 0 | $0 | 0.00% | −26,787−100.0% | Sold out |
| Corebridge Financial, Inc. | 0 | $0 | 0.00% | −26,760−100.0% | Sold out |
| State of Wyoming | 0 | $0 | 0.00% | −25,449−100.0% | Sold out |
| Empowered Funds, LLC | 0 | $0 | 0.00% | −18,840−100.0% | Sold out |
| Aigen Investment Management, LP | 0 | $0 | 0.00% | −16,159−100.0% | Sold out |
| Hennion & Walsh Asset Management, Inc. | 0 | $0 | 0.00% | −14,828−100.0% | Sold out |
| CIBC World Markets Corp | 0 | $0 | 0.00% | −12,120−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −11,596−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −11,544−100.0% | Sold out |
| HSBC Holdings PLC | 0 | $0 | 0.00% | −10,977−100.0% | Sold out |
| Algert Global LLC | 0 | $0 | 0.00% | −10,700−100.0% | Sold out |
| FORA Capital, LLC | 0 | $0 | 0.00% | −10,491−100.0% | Sold out |
| Sagefield Capital LP | 0 | $0 | 0.00% | −9,000−100.0% | Sold out |
| Point72 (DIFC) Ltd | 0 | $0 | 0.00% | −8,852−100.0% | Sold out |
| Quadrant Capital Group LLC | 0 | $0 | 0.00% | −4,859−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −2,647−100.0% | Sold out |
| Coldstream Capital Management Inc | 0 | $0 | 0.00% | −1,755−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −250−100.0% | Sold out |
| Boston Private Wealth LLC | 0 | $0 | 0.00% | −230−100.0% | Sold out |
| Clear Street Markets LLC | 0 | $0 | 0.00% | −127−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −79−100.0% | Sold out |
| Larson Financial Group LLC | 0 | $0 | 0.00% | −50−100.0% | Sold out |
| Continuum Advisory, LLC | 0 | $0 | 0.00% | −50−100.0% | Sold out |
| Sandy Spring Bank | – | – | – | – | Not filed |
| Lindbrook Capital, LLC | – | – | – | – | Not filed |